Curevac to report fourth quarter and full-year 2022 financial results and business updates on april 25, 2023

TÜbingen, germany and boston, ma / accesswire / april 18, 2023 / curevac n.v. (nasdaq:cvac), a biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid ("mrna"), will report financial results, and provide business updates for the fourth quarter and full-year 2022 on tuesday, april 25, 2023.

CVAC Ratings Summary

CVAC Quant Ranking